| Date | Time | Source | Headline | Symbol | Company |
| 07/26/2011 | 8:30AM | Business Wire | Impax Pharmaceuticals Completes Enrollment in ASCEND-PD Phase III Trial of IPX066 in Parkinson’s Disease | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/14/2011 | 8:30AM | Business Wire | Impax Pharmaceuticals Awarded Michael J. Fox Foundation Grant for Ongoing Research of IPX066 for Parkinson’s Disease | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/12/2011 | 10:00AM | Business Wire | Impax Laboratories Schedules Conference Call and Webcast for Second Quarter 2011 Financial Results | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/11/2011 | 6:10PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/11/2011 | 4:41PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 07/06/2011 | 7:59PM | Business Wire | Robbins Umeda LLP Announces an Investigation of Impax Laboratories, Inc. | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/30/2011 | 8:00AM | Business Wire | Impax Laboratories Announces Settlement of Litigation Relating to WELCHOL® Tablets and WELCHOL® Oral Suspension Products | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/22/2011 | 5:54PM | Edgar (US Regulatory) | Amended Statement of Changes in Beneficial Ownership (4/A) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/21/2011 | 11:30AM | Business Wire | Impax Laboratories Strengthens Leadership by Adding New Senior Vice Presidents for Global Operations and Global Quality Affairs | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/17/2011 | 11:00AM | Business Wire | Impax Laboratories to Present at the Wells Fargo Securities Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/16/2011 | 6:01AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/14/2011 | 5:46PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/09/2011 | 5:22PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/09/2011 | 5:12PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2011 | 4:14PM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/08/2011 | 2:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/06/2011 | 2:20PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/06/2011 | 8:04AM | Dow Jones News | Impax Labs Gets FDA Warning Letter For Calif Facility Issues | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/06/2011 | 7:00AM | Business Wire | Impax Laboratories Provides an Update on Recent FDA Site Inspection | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/03/2011 | 9:30AM | Business Wire | Impax Laboratories to Present at the Jefferies 2011 Global Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/03/2011 | 9:15AM | Business Wire | Impax Laboratories Confirms Patent Suit Relating to Generic Detrol® Immediate-Release 1 mg and 2 mg Tablets | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 06/01/2011 | 9:30AM | Business Wire | Data on IPX066 ADVANCE-PD & APEX-PD Phase III Studies to be Presented at the International Congress of Parkinson’s Disease ... | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/31/2011 | 6:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/31/2011 | 6:52PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/31/2011 | 6:51PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/31/2011 | 6:50PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/31/2011 | 4:05PM | Business Wire | Impax Laboratories to Present at the Goldman Sachs Annual Global Healthcare Conference | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/24/2011 | 8:33PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/24/2011 | 8:32PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |
| 05/24/2011 | 8:31PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:IPXL | Impax Laboratories, Inc. (delisted) |